Confirmed Aneurysmal SAH
CT/LP positive, aneurysm identified on CTA/DSA
All Pathways
NeurosurgeryManagement
Aneurysmal SAH - Neurosurgical Management (AHA 2023)
Aneurysmal SAH - Neurosurgical Management (AHA 2023): Confirmed Aneurysmal SAH → Initial Stabilization → Clinical Grading → Aneurysm Characteristics → A...
Pathway Overview
17 steps
Algorithm Steps
17 total
01Start 02Action Initial Stabilization
Prevent rebleeding before aneurysm secured
- ICU admission
- SBP target <160 mmHg (AHA Class I)
- Avoid Valsalva (stool softeners, antiemetics)
- Pain control (avoid excessive sedation)
- Bed rest, quiet environment
- Hold anticoagulation/antiplatelets
03Action Clinical Grading
Assess severity and prognosis
- Hunt-Hess Grade:
- I: Asymptomatic/mild headache
- II: Moderate headache, CN palsy
- III: Drowsy, mild focal deficit
- IV: Stuporous, hemiparesis
- V: Coma, decerebrate posturing
- Modified Fisher Grade (CT blood pattern)
- WFNS Grade (GCS-based)
04Action Aneurysm Characteristics
DSA gold standard - assess morphology
- Location (anterior vs posterior circulation)
- Size (small <7mm, large 7-25mm, giant >25mm)
- Neck width (narrow vs wide >4mm)
- Dome-to-neck ratio
- Presence of branches from dome
- Associated hematoma
- Multiple aneurysms?
05Decision Aneurysm Location?
Primary factor in treatment selection
06Action Posterior Circulation
Coiling preferred (Class I, Level B-R)
- Basilar tip, PICA, SCA, PCA aneurysms
- Endovascular coiling strongly preferred
- Surgical clipping technically challenging
- Higher surgical morbidity
- Consider flow diversion if not coilable
07Action Factors Favoring Coiling
Endovascular approach
- Good-grade SAH (H-H I-III)
- Age >70
- Posterior circulation
- Small neck (<4mm)
- Medical comorbidities
- 1-year outcomes better with coiling (ISAT)
- Lower procedural morbidity
08Warning Treatment Timing
Within 24 hours if possible (AHA Class IIa)
- Early treatment reduces rebleeding risk
- Facilitates vasospasm management
- Within 72 hours strongly recommended
- Poor-grade may benefit from delayed treatment
- Avoid surgery days 4-10 (vasospasm window)
09Action Endovascular Coiling
Catheter-based aneurysm obliteration
- Simple coiling for favorable anatomy
- Balloon-assisted for wide neck
- Stent-assisted if needed (requires antiplatelets)
- WEB device for bifurcation aneurysms
- Flow diversion for select cases
- Intraprocedural rupture risk ~2-3%
10Action Vasospasm Prevention
Days 3-14 highest risk
- Nimodipine 60mg PO/NG q4h x 21 days (Class I)
- Euvolemia (avoid hypovolemia)
- Monitor for DCI (neuro exams, TCD)
- TCD: MCA velocity >120 cm/s concerning
- CT perfusion if neurological change
11Action DCI Treatment
Delayed cerebral ischemia management
- Induced hypertension (SBP 180-220 if secured)
- IV fluids to optimize volume
- Intra-arterial vasodilators (verapamil, nicardipine)
- Balloon angioplasty for focal vasospasm
- Avoid hypotension, hypoxia, fever
12Action Long-term Follow-up
Surveillance for recurrence
- Coiled: MRA/DSA at 6 months, then annual
- Clipped: DSA postop, then clinical follow-up
- Higher recurrence rate with coiling (~20%)
- Re-treatment may be needed
- Screening family members if multiple aneurysms
13Outcome Outcomes
Prognosis depends on grade and complications
- Good outcome (mRS 0-2): 60-70% overall
- Hunt-Hess I-II: >80% good outcome
- Hunt-Hess IV-V: <30% good outcome
- Mortality: 30-40% overall
- Long-term cognitive deficits common
14Action Hydrocephalus Management
Common complication (20-30%)
- EVD if acute hydrocephalus with deterioration
- Serial LPs may suffice if mild
- VP shunt if persistent (10-20%)
- Monitor for infection
- Path rejoins step 12Shared downstream outcome
15Action Microsurgical Clipping
Craniotomy + clip application
- Pterional approach (most common)
- Temporary clipping to soften dome
- Definitive clip placement
- ICG angiography to confirm exclusion
- Evacuate hematoma if present
- Postop DSA to confirm obliteration
- Path rejoins step 10Shared downstream outcome
16Decision Anterior Circulation
Both options viable - consider factors
- ACA, AComm, MCA, ICA aneurysms
- Coiling: preferred for good-grade (Class I, Level A)
- Clipping: may be preferred for wide-neck, MCA bifurcation
- MDT discussion recommended
- Path rejoins step 07Shared downstream outcome
17Action Factors Favoring Clipping
Microsurgical approach
- Wide neck (>4mm)
- MCA bifurcation aneurysms
- Large intracerebral hematoma needing evacuation
- Branch vessel arising from dome
- Young age (durability concern)
- Failed coiling attempt
- Giant aneurysms
- Path rejoins step 08Shared downstream outcome
Guideline Source
AHA/ASA 2023 Guidelines for Management of Patients with Aneurysmal Subarachnoid Hemorrhage
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Complex aneurysm morphology requires multidisciplinary discussion
- Flow diversion for ruptured aneurysms still evolving
- Institutional expertise affects treatment selection
- Pediatric SAH not specifically addressed
- Mycotic aneurysms require different approach
Applicable Regions
USEU
EU: ESO guidelines similar recommendations
US: AHA 2023 - current standard of care
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Aneurysmal SAH - Neurosurgical Management (AHA 2023)?
The Aneurysmal SAH - Neurosurgical Management (AHA 2023) is a management clinical algorithm for Neurosurgery. It provides a structured decision tree to guide clinical decision-making, based on AHA/ASA 2023 Guidelines for Management of Patients with Aneurysmal Subarachnoid Hemorrhage.
What guideline is the Aneurysmal SAH - Neurosurgical Management (AHA 2023) based on?
This algorithm is based on AHA/ASA 2023 Guidelines for Management of Patients with Aneurysmal Subarachnoid Hemorrhage (DOI: 10.1161/STR.0000000000000436).
What are the limitations of the Aneurysmal SAH - Neurosurgical Management (AHA 2023)?
Known limitations include: Complex aneurysm morphology requires multidisciplinary discussion; Flow diversion for ruptured aneurysms still evolving; Institutional expertise affects treatment selection; Pediatric SAH not specifically addressed; Mycotic aneurysms require different approach. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Aneurysmal SAH - Neurosurgical Management (AHA 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free